Indofarma Tbk (INAF) — Capital Reinvestment Ratio
Latest as of December 2024:
0.00x
Indofarma Tbk (INAF) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (Rp34.01 Billion) in capital expenditures (Rp6.94 Million). See Indofarma Tbk free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
Rp34.01 Billion
IDR
Capital Expenditures
Rp6.94 Million
IDR
Data as of
Dec 2024
Most recent filing
Indofarma Tbk Capital Reinvestment Ratio (2000–2021)
This chart tracks Indofarma Tbk's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Indofarma Tbk (2000–2021)
Year-by-year Capital Reinvestment Ratio for Indofarma Tbk from 2000 to 2021. For live market cap and broader valuation context, see Indofarma Tbk (INAF) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.23x | Rp92.90 Billion | Rp21.40 Billion | ▼ -22.2% |
| 2020 | 0.30x | Rp46.55 Billion | Rp13.78 Billion | ▲ +137.0% |
| 2019 | 0.12x | Rp20.79 Billion | Rp2.60 Billion | ▼ -80.6% |
| 2017 | 0.64x | Rp147.18 Billion | Rp94.87 Billion | ▲ +277.1% |
| 2015 | 0.17x | Rp134.28 Billion | Rp22.95 Billion | ▼ -54.6% |
| 2014 | 0.38x | Rp148.73 Billion | Rp56.05 Billion | ▲ +140.7% |
| 2011 | 0.16x | Rp29.40 Billion | Rp4.60 Billion | ▼ -33.3% |
| 2010 | 0.23x | Rp23.71 Billion | Rp5.57 Billion | ▼ -56.0% |
| 2009 | 0.53x | Rp40.56 Billion | Rp21.65 Billion | ▲ +1507.3% |
| 2007 | 0.03x | Rp83.42 Billion | Rp2.77 Billion | ▲ +44.4% |
| 2006 | 0.02x | Rp73.15 Billion | Rp1.68 Billion | ▲ +470.4% |
| 2004 | 0.00x | Rp159.25 Billion | Rp642.02 Million | ▼ -98.0% |
| 2003 | 0.21x | Rp40.70 Billion | Rp8.36 Billion | ▼ -89.2% |
| 2000 | 1.90x | Rp27.05 Billion | Rp51.43 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow